https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Transcriptional analysis of the laccase-like gene from Burkholderia cepacia BNS and expression in Escherichia coli https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47840 Wed 01 Feb 2023 15:41:54 AEDT ]]> Burkholderia cepacia in cystic fibrosis: novel Australian cluster strain without accelerated respiratory deterioration https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:12952 1) (94.2% ± 16.7 vs 85.9% ± 21.2; P = 0.19) were not significantly different. The averaged annual fall in FEV1 over 4 years was also not significantly different (3.8% ± 3.8 vs 3.6% ± 3.7; P = 0.82). Weight percentile (Wt%), height percentile (Ht%) and percentage age weight for height (%WFH) were not significantly different between groups in 1993. By 1997, Wt% (36.7% ± 25.1 vs 22.3% ± 19.6; P = 0.04) and Ht% (42.5% ± 29.6 vs 17.6% ± 19.4; P = 0.002) but not %WFH (102% ± 10.0 vs 106% ± 11.2; P > 0.10) were lower in subjects with B. cepacia. Conclusions: In adolescent CF patients, colonization with the Hunter strain of B. cepacia was associated with a deterioration in some nutritional parameters but not with an accelerated decline in FEV1 over 4 years. As varying pathogenicity of B. cepacia strains may account for differing rates of pulmonary decline, further assessment of the consequences of colonization with certain strains of B. cepacia in CF is needed.]]> Sat 24 Mar 2018 08:18:28 AEDT ]]> Burkholderia cepacia immobilized onto rGO as a biomaterial for the removal of naphthalene from wastewater https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52286 Mon 09 Oct 2023 10:12:21 AEDT ]]> Global burden, point sources, and outbreak management of healthcare-associated Burkholderia cepacia infections: an integrative review https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:40007 Burkholderia cepacia healthcare-associated infections (HAIs). Design: Integrative review. Methods: A review of all outbreaks of Burkholderia cepacia HAIs published in the peer-reviewed literature between January 1970 and October 2019 was conducted to identify the global burden, associated point sources, and successful prevention and control measures using the Guidelines for Outbreak Reports and Intervention Studies of Nosocomial Infections (ORION). Results: In total, we reviewed 125 documented outbreaks of Burkholderia cepacia–related HAIs worldwide. The reported B. cepacia HAIs for this period involved 3,287 patients. The point sources were identified in most outbreaks of B. cepacia HAIs (n = 93; 74.4%); they included medication vials, disinfectants, and antiseptics. Moreover, 95 of the outbreak reports (76%) described effective prevention and control measures, but only 33 reports indicated the use of a combination of environment-, patient- and staff-related measures. None of the outbreak reports used the ORION guidelines. Conclusions: Outbreaks of Burkholderia cepacia HAIs are an ongoing challenge. They are often associated with immunocompromised patients who acquire the infection from exposure to contaminated medications, products, and equipment. These outbreaks are not infrequent, and a range of infection prevention and control measures have been effective in arresting spread. The use of ORION guidelines for outbreak reporting would improve the quality of information and data to generate evidence for translation into practice.]]> Fri 15 Jul 2022 10:11:13 AEST ]]>